EUVIMEDEUVIMED entdecken
Crossref

Cerium Oxide Doped Prussian Blue Nanoparticles for Targeted Modulation of the Myocardial Injury Microenvironment and Theranostics of Doxorubicin‐Induced Cardiomyopathy

Zhi-Nan Wang iD, Xi Liu, Xiaowei Zhu, Shidong Hu, Kun Zhang, Xiao-Ting Li, Bin En Nie, Ying-Shi Sun iD

Small · 2025-12 · 21 (49)

DOI: 10.1002/smll.202508419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 22.10.2025. Verfasst von Zhi-Nan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Radiology, Peking University Cancer Hospital & Inst…. Hauptthemen laut MEDLINE: Cerium, Ferrocyanides, Doxorubicin, Cardiomyopathies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX), a widely used anthracycline chemotherapeutic, is clinically limited by cumulative and dose‐dependent cardiotoxicity. Oxidative stress and inflammation are central pathogenic mechanisms of DOX‐induced cardiomyopathy (DIC), characterized by extensive innate immune cells infiltration into the injured myocardium. The immune landscape of DIC mouse models is systematically characterized, identifying macrophages as the predominant immune subset. Based on this, a hybrid nanozyme (PB@CeO 2 NPs) is developed, comprising Prussian blue nanoparticles (PB NPs) and cerium oxide nanoparticles (CeO 2 NPs). The PB NPs core provides magnetic resonance imaging (MRI) contrast, while CeO 2 NPs surface modification enhances immune cell uptake, promotes retention in inflamed cardiac tissue, and augments reactive oxygen species (ROS) scavenging and anti‐inflammatory efficacy. In vitro experiments demonstrate that PB@CeO 2 NPs alleviate mitochondrial damage, inhibit apoptosis, and induce macrophage M2 polarization. In vivo studies show that PB@CeO 2 NPs facilitate myocardial accumulation, reduce cardiac inflammation and fibrosis, and improve cardiac function. By integrating the antioxidative and anti‐inflammatory effects of PB@CeO 2 NPs with inflammation‐mediated immune cell retention in injured myocardium, this study presents a promising nanotherapeutic platform for targeted and precise intervention in anthracycline‐induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeriumFerrocyanidesDoxorubicinCardiomyopathiesNanoparticlesTheranostic NanomedicineMyocardiumAnimalsMiceMice, Inbred C57BLMagnetic Resonance ImagingMacrophagesMaleReactive Oxygen Species

Stichwörter der Autor:innen

cardioprotectiondoxorubicin‐induced cardiomyopathyhybrid nanozymeinflammatory microenvironmentoxidative stress

Substanzen

CeriumFerrocyanidesceric oxideferric ferrocyanideDoxorubicinReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, No.28 Fu Xing Road, Hai Dian District, Beijing, 100853, China.
  • Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Children's Medicine Key Laboratory of Sichuan Province, West China Second…
  • Department of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.

ORCID-Profile: Zhi-Nan Wang, Ying-Shi Sun

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Wang, Z. N., Liu, X., Zhu, X., Hu, S., Zhang, K., Li, X. T., Nie, B. E., & Sun, Y. S. (2025). Cerium Oxide Doped Prussian Blue Nanoparticles for Targeted Modulation of the Myocardial Injury Microenvironment and Theranostics of Doxorubicin‐Induced Cardiomyopathy. Small, 21(49). https://doi.org/10.1002/smll.202508419

Vancouver

Wang ZN, Liu X, Zhu X, Hu S, Zhang K, Li XT, et al. Cerium Oxide Doped Prussian Blue Nanoparticles for Targeted Modulation of the Myocardial Injury Microenvironment and Theranostics of Doxorubicin‐Induced Cardiomyopathy. Small. 2025;21(49). doi:10.1002/smll.202508419

BibTeX
@article{Wang2025,
  author = {Wang, Zhi-Nan and Liu, Xi and Zhu, Xiaowei and Hu, Shidong and Zhang, Kun and Li, Xiao-Ting and Nie, Bin En and Sun, Ying-Shi},
  title = {Cerium Oxide Doped Prussian Blue Nanoparticles for Targeted Modulation of the Myocardial Injury Microenvironment and Theranostics of Doxorubicin‐Induced Cardiomyopathy},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {49},
  doi = {10.1002/smll.202508419}
}
Kostenlos starten →